The Cancer Epigenetics Society, launched only last year, continues to be ever more popular, with more people from more countries using its resources.
In the social media such as LinkedIn, the Cancer Epigenetics Society has now a similar size audience as that of EpiCypher (founded in 2012), EpiGentek (founded in 2005), and the Max-Planck Institute of Immunobiology and Epigenetics (founded in 1961).
The Cancer Epigenetics Society website has also become very popular with many more unique users and page views than ever before. According to Alexa website rankings, the Cancer Epigenetics Society web pages have climbed more than 20 million spots in the last 6 months to now rank among the top 0.5% most visited sites in the web.
The Cancer Epigenetics Society is also now the largest epigenetics society and the second most international cancer society worldwide, with members from over 150 countries. This puts the Cancer Epigenetics Society in the same league as other highly diversified cancer societies and associations, including the American Association for Cancer Research (AACR, founded in 1907, 98 countries), American Society of Clinical Oncology (ASCO, founded in 1964, over 120 countries), and European Association for Cancer Research (EACR, founded in 1968, over 100 countries).
The Cancer Epigenetics Society will continue to expand and diversify its services, and looks forward to working with interested institutions and individuals worldwide to advance cancer epigenetics research and discovery (Cancer Epigenetics Society news, July 17, 2017).